Concentra Group Parent (CON) vs GRAIL (GRAL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GRAIL (GRAL) has outperformed Concentra Group Parent (CON) over the past year, gaining 111.6% versus a gain of 73.7%. GRAIL is the larger company by market cap ($5.94 billion vs $4.64 billion), about 1.3 times the size. Concentra Group Parent pays a dividend yielding 0.69%, while GRAIL does not currently pay one.
Concentra Group Parent converts more of its revenue into profit, with a net margin of 7.7% versus -277.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CON | GRAL |
|---|---|---|
| Share price | $36.40 | $132.90 |
| Market cap | $4.64B | $5.94B |
| 1-day change | 0.00% | -3.19% |
| YTD return | +84.96% | +55.28% |
| 1-year return | +73.66% | +111.56% |
| P/E ratio (TTM) | 23.48 | — |
| Forward P/E | 19.77 | — |
| EPS (TTM) | $1.55 | $-9.39 |
| Dividend yield | 0.69% | 0.00% |
| Annual dividend | $0.25 | $0.00 |
| Revenue (latest FY) | $2.16B | $147.17M |
| Revenue growth (YoY) | +13.85% | +17.18% |
| Net income (latest FY) | $166.41M | $-408.35M |
| Gross margin | 28.34% | — |
| Operating margin | 15.44% | -381.98% |
| Net margin | 7.69% | -277.47% |
| 52-week high | $36.83 | $166.48 |
| 52-week low | $18.55 | $41.50 |
| Distance from 52-week high | -1.17% | -20.17% |
| Analyst consensus | none | buy |
| Avg. price target upside | +12.64% | -15.43% |
| Average volume | 912.62K | 930.77K |
| Shares outstanding | 127.52M | 44.67M |
| Employees | 9,967 | 910 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRAL has outperformed CON by 37.9 percentage points over the past year.
- Concentra Group Parent is more profitable, keeping 7.7 cents of every revenue dollar as net income versus -277.5 cents for GRAIL.
About Concentra Group Parent
CON stock →Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.
Health Care · Medical Specialities · 9,967 employees
About GRAIL
GRAL stock →GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer.
Health Care · Medical Specialities · 910 employees
CON vs GRAL FAQ
Which is bigger, Concentra Group Parent or GRAIL?
GRAIL (GRAL) is larger, with a market capitalization of $5.94B compared with $4.64B for Concentra Group Parent (CON).
Which stock has performed better over the past year, CON or GRAL?
GRAL returned +111.56% over the past 12 months, compared with +73.66% for CON (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Concentra Group Parent or GRAIL?
Concentra Group Parent pays a dividend yielding 0.69%, while GRAIL does not currently pay a regular dividend.
Are Concentra Group Parent and GRAIL in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.